Mylan and Aspen launch generic Busulfex Injection [Seeking Alpha]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Seeking Alpha
Mylan and Aspen launch generic Busulfex InjectionMylan N.V. (NASDAQ:MYL) and its partner, Aspenannounces the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Otsuka Pharmaceutical's Busulfex Injection.This product is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.As part of its partnership with Aspen, Mylan will commercialize Busulfan Injection, 60 mg/10 mL (6 mg/mL) in the U.S.According to IQVIA, U.S. sales for Busulfan Injection were ~$97M for the year ending Sept. 30.Shares of Mylan are up2% premarket.See all stocks on the move »
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Strategies for Biomarker-Driven Sub-population Optimization in Clinical Trials, Upcoming Webinar Hosted by XtalksPR Web
- Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly [Yahoo! Finance]Yahoo! Finance
- IQVIA to Announce First-Quarter 2024 Results on May 2, 2024Business Wire
- Global In Vivo CRO Market Analysis Report 2024-2030, Featuring IQVIA, Crown Bioscience, Taconic Biosciences, PsychoGenics, Evotec, Janvier Labs, Biocytogen Boston, GemPharmatech and Parexel [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/14/24 - Beat
IQV
Sec Filings
- 4/17/24 - Form 8-K
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- IQV's page on the SEC website